Exchange: NASDAQ·Updated 05:59 PM EDT
ORGO logo

ORGOOrganogenesis Holdings Inc - Ordinary Shares - Class A

$2.36
$0.08
(3.28%)
Today
Closed $2.36
$0.03
(1.27%)
After Hours
EarningsAug 6
Mkt Cap$303.67M
Vol757,975.00
News
all
press releases
The Body as Blueprint: A Recently Public Biotech Bets That Regrown Tissue Beats Replacement Parts
The Body as Blueprint: A Recently Public Biotech Bets That Regrown Tissue Beats Replacement Parts The Body as Blueprint: A Recently Public Biotech Bets That Regrown Tissue Beats Replacement Parts PR Newswire TAMPA, Fla., June 2, 2026 Issued on behalf of Conexeu Sciences Inc.A newly listed...
PR Newswire
News Placeholder
More News
News Placeholder
Organogenesis (ORGO) Projected to Post Earnings on Thursday
Organogenesis (NASDAQ:ORGO) will be releasing its Q1 2026 earnings after the market closes on Thursday, May 7. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2026-5-7-organogenesis-holdings-inc-stock...
MarketBeat
News Placeholder
Organogenesis (NASDAQ:ORGO) Trading Up 1.7% - Time to Buy?
Organogenesis (NASDAQ:ORGO) Shares Up 1.7% - What's Next...
MarketBeat
News Placeholder
ORGO Stock Rallies After Hours On Clearing Regulatory Pathway For Pain Relief Treatment
Organogenesis is seeking approval for ReNu in knee osteoarthritis pain, a degenerative joint disease that is estimated to affect nearly 31.1 million Americans.
Stocktwits
News Placeholder
Organogenesis (NASDAQ:ORGO) Receives "Buy" Rating from BTIG Research
BTIG Research reissued a "buy" rating and issued a $8.00 price objective on shares of Organogenesis in a research report on Thursday...
MarketBeat
News Placeholder
Assenagon Asset Management S.A. Acquires 680,392 Shares of Organogenesis $ORGO
Assenagon Asset Management S.A. raised its stake in shares of Organogenesis (NASDAQ:ORGO - Free Report) by 14.0% during the fourth quarter, according to its most recent disclosure with the Securities...
MarketBeat
News Placeholder
Organogenesis $ORGO Shares Acquired by First Light Asset Management LLC
First Light Asset Management LLC lifted its stake in shares of Organogenesis (NASDAQ:ORGO - Free Report) by 10.6% during the 3rd quarter, according to the company in its most recent filing with the...
MarketBeat
News Placeholder
Insider Buying: Organogenesis (NASDAQ:ORGO) Director Buys 5,000 Shares of Stock
Organogenesis (NASDAQ:ORGO - Get Free Report) Director Arthur Leibowitz purchased 5,000 shares of the stock in a transaction on Monday, March 9th. The stock was acquired at an average cost of $2.68...
MarketBeat
News Placeholder
Michael Joseph Driscoll Buys 10,000 Shares of Organogenesis (NASDAQ:ORGO) Stock
Organogenesis (NASDAQ:ORGO - Get Free Report) Director Michael Joseph Driscoll purchased 10,000 shares of the business's stock in a transaction on Monday, March 9th. The shares were purchased at an...
MarketBeat
News Placeholder
Insider Buying: Organogenesis (NASDAQ:ORGO) Director Buys $13,400.00 in Stock
Organogenesis (NASDAQ:ORGO - Get Free Report) Director Arthur Leibowitz acquired 5,000 shares of the firm's stock in a transaction on Monday, March 9th. The shares were acquired at an average price...
MarketBeat
<
1
2
...
>

Advertisement|Remove ads.